NASDAQ:HUMAW

Humacyte Stock Forecast

etoro logo Buy HUMAW
*Your capital is at risk
$0.0466
-0.0085 (-15.36%)
At Close: Jun 03, 2026
AI Analysis AI Analysis of HUMAW AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add HUMAW to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Is Humacyte, Inc. stock still a buy after falling -15.36% on Wednesday?
(Updated on Jun 03, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since May 29, 2026 Loss -7.46%

The Humacyte, Inc. stock price fell by -15.36% on the last day (Wednesday, 3rd Jun 2026) from $0.0550 to $0.0466. During the last trading day the stock fluctuated 0.110% from a day low at $0.0465 to a day high of $0.0466. The price has fallen in 5 of the last 10 days and is down by -25.76% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -44 thousand shares and in total, 2 thousand shares were bought and sold for approximately $85.33 .

The stock has broken the very wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($0.0484) are considered to be a "second chance" to get out. According to the fan-theory -$0.0153 will represent the new bottom line of the next trend, but it is far too early to say this for certain.

HUMAW Signals & Forecast

There are few to no technical positive signals at the moment. The Humacyte, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0628 and $0.0785. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, June 01, 2026, and so far it has fallen -33.40%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Humacyte, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.000051 between high and low, or 0.110%. For the last week the stock has had daily average volatility of 111.44%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (HUMAW) For The Upcoming Trading Day Of Thursday 4th

For the upcoming trading day on Thursday, 4th we expect Humacyte, Inc. to open at $0.0466, and during the day (based on 14 day Average True Range), to move between $0 and $0.0954, which gives a possible trading interval of +/-$0.0977 (+/-95 412.24%) up or down from last closing price. If Humacyte, Inc. takes out the full calculated possible swing range there will be an estimated 95 412.24% move between the lowest and the highest trading price during the day. ⚠️ Extreme Volatility Warning: The projected daily trading range exceeds 1000%, indicating exceptionally high volatility. This level of price movement suggests significant market uncertainty and elevated risk. Traders should exercise extreme caution, consider reduced position sizes, and implement strict risk management strategies when trading this security.

With no support below and resistance from accumulated volume @ $0.0503, some $0.0038 (8.06%) from the current price of $0.0466, our system finds the risk reward not very attractive.

Is Humacyte, Inc. stock A Buy?

Humacyte, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -8.625 Strong Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on June 4, 2026 - $0.0466 ( 0.0351%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

HUMAW Performance

Trading levels for HUMAW

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.0466 0.145%
R2 0.0466 0.103%
R1 0.0466 0.0769%
Price 0.0466
S1 0.0465 -0.0068%
S2 0.0465 -0.0326%
S3 0.0465 -0.0745%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.0567 21.80%
R2 0.0550 18.15%
R1 0.0503 8.06%
Price 0.0466
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Humacyte, Inc. Stock and on which exchange is it traded?
The symbol for Humacyte, Inc. is HUMAW and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Humacyte, Inc. Stock?
Humacyte, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Humacyte, Inc. Stock?
Humacyte, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Humacyte, Inc. Stock.

What's the current price of Humacyte, Inc. Stock?
As of the end of day on the Jun 03, 2026, the price of an Humacyte, Inc. (HUMAW) share was $0.0466.

What is the 52-week high and low for Humacyte, Inc. Stock?
The 52-week high for Humacyte, Inc. Stock is $0.600 and the 52-week low is $0.0400.

What is the market capitalization of Humacyte, Inc. Stock?
As of the Jun 03, 2026, the market capitalization of Humacyte, Inc. is 56.031M.

When is the next earnings date for Humacyte, Inc.?
The upcoming earnings date for Humacyte, Inc. is Aug 17, 2026.
Click to get the best stock tips daily for free!
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE